» Articles » PMID: 30715247

Common Risk Factors for Heart Failure and Cancer

Overview
Journal Cardiovasc Res
Date 2019 Feb 5
PMID 30715247
Citations 126
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular (CV) disease and cancer are the leading causes of death.1,2 Over the last decades, it has been appreciated that both CV disease and cancer are more common in individuals in whom risk factors for disease development accumulate, and preventative measures have been extremely important in driving down the incidence of disease.3-6 In general, the field of epidemiology, risk reduction, and preventative trials is divided into health care professionals who have an interest in either CV disease or cancer. As a result, the medical literature and medical practice has largely focused on the one disease, or the other. However, human individuals do not behave according to this dogma. Emerging data clearly suggest that identical risk factors may lead to CV disease in the one individual, but may cause cancer in another, or even both diseases in the same individual. This overlap exists between risk factors that are historically classified as 'CV risk factors' as these factors do equally strong predict cancer development. Therefore, we propose that a holistic approach might better estimate actual risks for CV disease and cancer. In this review, we summarize current insights in common behavioural risk factors for heart failure, being the most progressed and lethal form of CV disease, and cancer.

Citing Articles

The Cardiotoxicity Risk of Immune Checkpoint Inhibitors Compared with Chemotherapy: A Systematic Review and Meta-analysis of Observational Studies.

Zheng Y, Liu Z, Chen D, Zhang J, Yuan M, Zhang Y Cardiovasc Toxicol. 2025; .

PMID: 40053271 DOI: 10.1007/s12012-025-09979-1.


A meta-analysis on the impact of concurrent or pre-existing cancer diagnosis on acute myocardial infarction outcomes.

Wang J, Yu J PLoS One. 2025; 20(1):e0318437.

PMID: 39888923 PMC: 11785289. DOI: 10.1371/journal.pone.0318437.


Lifestyle scores and their potential to estimate the risk of multiple non-communicable disease-related endpoints: a systematic review.

Ding J, Fu R, Yuan T, Brenner H, Hoffmeister M BMC Public Health. 2025; 25(1):293.

PMID: 39849411 PMC: 11758753. DOI: 10.1186/s12889-025-21537-6.


Reviewing the path to balance: mechanisms and management of hypertension associated with targeting vascular endothelium in cancer therapy.

Si F, Ma X, Liu Q, Yu J Hypertens Res. 2025; 48(3):1034-1047.

PMID: 39820066 DOI: 10.1038/s41440-024-02086-8.


Cardiovascular Disease and Cancer: A Dangerous Liaison.

Newman A, Dalman J, Moore K Arterioscler Thromb Vasc Biol. 2025; 45(3):359-371.

PMID: 39781742 PMC: 11864891. DOI: 10.1161/ATVBAHA.124.319863.


References
1.
Koene R, Prizment A, Blaes A, Konety S . Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016; 133(11):1104-14. PMC: 4800750. DOI: 10.1161/CIRCULATIONAHA.115.020406. View

2.
Hofmann U, Frantz S . Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ Res. 2015; 116(2):354-67. DOI: 10.1161/CIRCRESAHA.116.304072. View

3.
Meijers W, Maglione M, Bakker S, Oberhuber R, Kieneker L, de Jong S . Heart Failure Stimulates Tumor Growth by Circulating Factors. Circulation. 2018; 138(7):678-691. DOI: 10.1161/CIRCULATIONAHA.117.030816. View

4.
Akinyemiju T, Wiener H, Pisu M . Cancer-related risk factors and incidence of major cancers by race, gender and region; analysis of the NIH-AARP diet and health study. BMC Cancer. 2017; 17(1):597. PMC: 5577755. DOI: 10.1186/s12885-017-3557-1. View

5.
Timmis A, Townsend N, Gale C, Grobbee R, Maniadakis N, Flather M . European Society of Cardiology: Cardiovascular Disease Statistics 2017. Eur Heart J. 2017; 39(7):508-579. DOI: 10.1093/eurheartj/ehx628. View